DGNMF (Diagnamed Holdings) Tariff Resilience Score: 6/10 (As of Jul. 05, 2026)


What is Diagnamed Holdings Tariff Resilience Score?

Diagnamed Holdings DGNMF Tariff Resilience Score is 6 as of Jul. 05, 2026. The stock has 1 warning sign investors should review. Among 675 Healthcare Providers & Services companies, Diagnamed Holdings ranks better than 83.56% on this metric.

Diagnamed Holdings has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Diagnamed Holdings has Diagnamed Holdings Corp operates in the healthcare sector, with some exposure to tariffs on medical equipment imports. Its focus on innovation and potential for alternative sourcing provides moderate resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Diagnamed Holdings might have Average Resilient.

Diagnamed Holdings  (OTCPK:DGNMF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Diagnamed Holdings Tariff Resilience Score Related Terms

DGNMF vs VEEV, BTSG, TEM: Tariff Resilience Score Comparison

For the Health Information Services subindustry, Diagnamed Holdings's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diagnamed Holdings Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnamed Holdings's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Diagnamed Holdings's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 6 mean?
Diagnamed Holdings (DGNMF) has a Tariff Resilience Score of 6 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Diagnamed Holdings ranks #111 out of 675 companies in the Healthcare Providers & Services industry, placing it in the top 16.4%.
Is Diagnamed Holdings' Tariff Resilience Score too high?
Diagnamed Holdings' current Tariff Resilience Score is 6. Based on the distribution chart, Diagnamed Holdings ranks #111 out of 675 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Diagnamed Holdings' Tariff Resilience Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Diagnamed Holdings ranks #111 out of 675 companies for Tariff Resilience Score. This places Diagnamed Holdings in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Diagnamed Holdings's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnamed Holdings stock overvalued right now?
Diagnamed Holdings (DGNMF) has a current Tariff Resilience Score of 6. The current Tariff Resilience Score is 6. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Diagnamed Holdings (DGNMF), the current Tariff Resilience Score is 6 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diagnamed Holdings Business Description

Other Exchanges DMED:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.